![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 3, 1827-1839, January 20, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Pharmacology and Biological Chemistry, Mount Sinai School of Medicine, New York, New York 10029
Received for publication, August 10, 2005 , and in revised form, October 20, 2005.
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|

subunits with the
1 pore-forming subunit of the channel (2, 3). In addition, phosphorylation by kinases such as protein kinase C and tyrosine kinases has been shown to inhibit Ca2+ channels (4). Subsequent work has established that G protein-dependent inhibition of calcium current is in part a result of a decrease in the open probability of the channel, reducing current density (57). The idea that changes in channel density could underlie calcium channel modulation has not been tested. Activity- and receptor-dependent trafficking of ionotropic receptors has been widely studied in the post-synaptic density (8, 9). Such studies have not been extended to proteins in the presynaptic active zones. In this study we have found that activation of G protein-coupled receptors induces destabilization and subsequent removal of calcium channels from the plasma membrane. Transmitter-induced trafficking of calcium channels is a consequence of disrupting the interaction of the channel with L1-CAM and ankyrin B and might represent a novel mechanism of presynaptic inhibition.
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
1 (1:200) (1.5 µg/ml) (Alomone Labs, Jerusalem, Israel), mouse anti-clathrin heavy chain (1:200) (1.25 µg/ml) (BD Transduction Laboratories, San Jose, CA), mouse anti-Rab5 (1:200) (1.25 µg/ml) (BD Transduction Laboratories), mouse anti-chick Ng-CAM L1 (8D9) (1:100). The following secondary antibodies were used at a 1:200 dilution (10 µg/ml) in these studies: Alexa Fluor 488-conjugated goat anti-rabbit IgG (H+L), tetramethylrhodamine-conjugated goat anti-mouse IgG (H+L), Alexa Fluor 488-conjugated goat anti-mouse IgG (H+L), tetramethylrhodamine conjugated goat anti-mouse IgG (H+L) (Molecular Probes; Eugene, OR), and Cy3-conjugated goat anti-mouse IgG (H+L) (1:200) (7.5 µg/ml) (The Jackson Laboratory, Bar Harbor, ME).
PeptidesSequences of the 795814 peptide and a fluorescein peptide containing the scrambled sequence of N terminus 125 used in this study were based on the Cav2.2
1 sequence from chick dorsal root ganglion (DRG)3 neuron (CDB1, GenBankTM AAD51815
[GenBank]
). Peptides were synthesized by FastMoc chemistry at the Tufts University Core Facility (Boston, MA) and purified by high performance liquid chromatography with >97% purity as determined by mass spectrometry. An N-terminal biotin was included in every peptide; also, the N terminus included the sequence of the Antennapedia domain of penetratin. Peptides were dissolved in 5 mM acetic acid at 1 mg/ml and diluted into the internal solution for electrophysiological experiments or Hepes-buffered saline solution for biochemical experiments.
The fluoresceinated peptide contains the scrambled sequence from the N terminus of the
1 subunit, and no significant homology with other proteins was detected by BLAST search. Control experiments were performed, and no differences were detected between cells loaded with the peptide and unloaded cells.
For each peptide used in our studies we performed time course and concentration-response experiments to determine optimal experimental conditions. Pilot studies were conducted in which fluoresceinated peptides were used to assess peptide entry into the cells.
In terms of the effects on signaling pathways, AP-YF did not change baclofen-induced internalization. Electrophysiological experiments showed that the peptide from loop II-III did not disrupt G
-mediated pathways.
Cell CultureEmbryonic chick sensory neurons were grown in culture as previously described (Diversé-Pierluissi et al. (10).
ElectrophysiologyWhole-cell recordings were performed as described in Diversé-Pierluissi et al. (10). For extracellular application, agents were diluted into standard extracellular saline and applied via wide-bore pipette. For the experiments presented in this report, calcium current has been corrected for rundown by measuring calcium current as a function of time in control cells without transmitter. Cells used for experiments exhibited a rundown of the current of less than 1%/min.
The external saline contained 133 mM NaCl, 1 mM CaCl2, 0.8 mM MgCl2, 10 mM tetraethylammonium chloride, 25 mM HEPES, 12.5 mM NaOH, 5 mM glucose, and 0.3 µM tetrodotoxin. The pipette internal solution contained 150 mM CsCl, 10 mM HEPES, 5 mM MgATP, and 5 mM bis(o-aminophenoxy)-ethane-tetraacetic acid (BAPTA). Pipettes resistances before forming high resistance seals ranged from 1 to 2 megaohms.
Electrophysiology Data AnalysisData were filtered at 3 kHz, acquired at 1020 kHz, and analyzed using PulseFit (HEKA) and Igor-Pro (WaveMetrics) on a Macintosh G3 computer. Strong depolarizing conditioning pulses (to 80 mV) that precede test pulses (to 0 mV) reverse neurotransmitter-induced voltage-dependent inhibition without affecting voltage-independent inhibition. Such conditioning pulses had no effect on control currents recorded in the absence of neurotransmitter. During neurotransmitter application, test pulse currents measured before and after the conditioning pulse were subtracted to yield the voltage-dependent component. Test pulses measured after the conditioning pulse were subtracted from control currents (measured in the absence of neurotransmitter) to yield the voltage-independent component.
Living Neuron ExperimentsDRG neurons grown on glass-bottom culture dishes were preincubated with 250 nM tetramethylrhodamine-conjugated
-conotoxin GVIA (Molecular Probes, Eugene, OR) for 3 h in DRG medium at 30 °C in a CO2 incubator to minimize ligand-bound channel re-uptake. Cells were washed twice with 1 mM Ca2+ external buffer (1 mM CaCl2, 133 mM NaCl, 0.8 mM MgCl2, 10 mM tetraethylammonium chloride, 10 mM tetraethylammonium chloride, 25 mM HEPES, 12.5 mM NaOH, 5 mM dextrose, 0.3 µM tetrodotoxin (Calbiochem)) to remove unbound fluorophore conjugate. For live neuron experiments, 50 µM Trolox (final concentration) (Calbiochem), a water-soluble, cell-permeable derivative of vitamin E with antioxidant properties, was added to 1 mM Ca2+ external buffer to inhibit photobleaching. Images were taken every 2 s from the top surface of the cells. Specificity of
-conotoxin GVIA-tetramethylrhodamine conjugate labeling of Cav2.2 channels was determined by preincubating cells with unlabeled
-conotoxin GVIA (750 nM) and
-conotoxin GVIA-tetramethylrhodamine conjugate (250 nM) for 3 h at 30 °C in a CO2 incubator before confocal imaging.
In living neuron studies, images were scanned using a Zeiss LSM 510 META microscope in an inverted configuration with a pinhole setting of 1.0 using a UV Planapochromat 63x 1.4 NA oil objective at 2-s intervals in one x-y focal plane with the appropriate stage adapter configured for the Delta T controlled culture dish system fitted with a micro-perfusion pump and with the temperature control set at 25 °C (Bioptechs Inc., Butler, PA). To obtain optical slices at high speed, regions of interest were used. Fluorescence values as a function of time were measured using Zeiss Physiology Version 3.2 software.
Transmitter ApplicationTransmitters were prepared fresh in Hepes-buffered saline Ca2+ external buffer (2.5 mM KCl) at 100 mM concentrations (1000x) and
-aminobutyric acid (GABA) (Sigma) with and without baclofen (4-amino-3-[4-chlorophenyl] butanoic acid (Sigma)). Transmitter was diluted in the appropriate Hepes-buffered saline Ca2+ external buffer immediately before experiments. Cells were washed once with Hepes-buffered saline Ca2+ external buffer (2.5 mM KCl) at room temperature followed by the addition of 2 ml of Hepes-buffered saline Ca2+ external buffer (60 mM KCl) with or without a final concentration of 100 µM transmitter for 20 s or 5 min at room temperature.
AP-YF Peptide TreatmentPeptide Scr (scrambled) and peptide AP-YF were incubated 15 min at 37 °C before addition to DRG medium for a final concentration of 1.4 µg/ml. Cells were treated in the presence of peptide for 30 min in a CO2 incubator at 37 °C before saline or transmitter treatment.
ImmunohistochemistryCultures grown on poly-L-lysine glass coverslips were fixed and permeabilized in methanol at -20 °C for 15 min followed by 3x 5-min washes in PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM MgCl2, pH 6.9). Cells were alternatively fixed with 4% paraformaldehyde in PHEM buffer, pH 6.9, for 20 min, washed 3 x 3 min with PHEM buffer, and permeabilization with 0.1% Triton X-100, PHEM buffer for 3 min. Blocking was performed using 5% bovine serum albumin in PHEM buffer for 1 h at 4°C. Cells were incubated overnight with primary antibody in 1% bovine serum albumin and 1% normal goat sera in PHEM buffer at 4 °C. After washes with PHEM buffer, coverslips were incubated with fluorophore-conjugated secondary antibodies in 1% bovine serum albumin PHEM buffer for 1.5 h at room temperature in the dark. Glass coverslips were washed 4 times (5 min each) in 1% bovine serum albumin PHEM buffer and mounted on glass slides with one drop of Vectashield anti-fade reagent (Vector Laboratories, Burlingame, CA) and sealed.
Confocal ImagingConfocal laser-scanning microscopy was performed at the Mount Sinai School of Medicine Microscopy Shared Resource Facility using a Leica TCS-SP (UV) microscope in an inverted configuration. Images of fixed cells were obtained with a pinhole setting of 0.95 using a UV 100x 1.4 NA oil objective lens and an optical zoom between 1.4 and 2x at slow acquisition speed with 4x frame-averaging accumulation. The number of sections was calculated by the Leica TCS software based on acquisition of sections at 240-nm intervals in the z plane. Confocal z stack images were saved as individual z slices as well as average intensity two-dimensional projections.
Distribution Plots and AnalysisImages for distribution analysis were acquired using an Olympus BX60 microscope configured for fluorescence imaging and fitted with a cooled color CCD camera and an Optronix DEI-750D CE digital output frame grabber. Images were acquired using a 40x objective where imaging parameters were kept constant and were obtained at comparable focal planes. Additional images were taken with a 100x oil immersion objective for later analysis. Images were taken in successive non-overlapping steps, and 2030 images were typically acquired for each time point. Images were imported into Adobe Photoshop and normalized with the auto levels adjustment, and cells were scored for the number of puncta present on a grid.
The integrated density of each optical slice was measured, and the total surface and cytoplasmic intensity per pixel were calculated. Membrane and cytoplasmic staining were assessed by integrated density morphometric analysis using ImageJ (National Institutes of Health). We used regions of interest, and for every optical slice the whole area was defined as total fluorescence and the interior of the cell as the cytosolic fluorescence. The membrane fluorescence was defined as the difference of total cytosolic. The average membrane area was 1.5 ± 0.7 µm (n = 200). The integrated values were obtained by obtaining the fluorescence values as a function of area.
|
IP Labs image software analysis was performed on tiff format confocal images only, utilizing voxel-size parameters obtained from the stored Leica TCS NT data file. The cut-off intensity level was set at 50, and thresholds were maintained across the entire analysis. Each experimental condition was performed in duplicate, and the raw data were pooled. S.E. were calculated for frequency distribution plots using the binomial S.E. (
). Determinations of significance (p values) between the independent matched frequency distributions of saline alone controls and transmitter-treated groups were performed utilizing the
2 test, with a p value
0.05 judged as significant, using publicly available online software (Interactive Chi-Square) from Ohio State University, Department of Psychology.
|
1 subunit of the Cav2.2 channel was immunoprecipitated as previously described (11). Pull Down2 mg of rat brain lysate was incubated with 100 µg of His6-tagged recombinant protein bound to nickel beads for 4 h at 4°C. The beads were spun down and washed three times. Beads were mixed with 25 µl of Laemmli sample buffer and boiled for 5 min. After spinning down the beads, the supernatant sample was resolved by 7.5% SDS-acrylamide gel. Immunodetection of L1-CAM and ankyrin B was carried out using anti-L1-CAM (1:1000, 8D9 Developmental Studies Hybridoma Bank) and anti-ankyrin B (1:1000, BD Transduction Laboratories).
Secretion AssaySecretion of substance P was analyzed using the single-cell immunoblot method adapted from Huang and Neher (12). Briefly, polyvinylidene difluoride transfer membranes (Immobilon P brand from Millipore) were cut to 22 x 22 mm and placed in 6-well plates. Membranes were pre-wetted with methanol for 20 s, rinsed with distilled water, and allowed to equilibrate in test solution for >1 h. In parallel, DRG cells plated were incubated with media containing AP-YF or AP-Scr (1.4 µg/ml) for 1 h. This medium was removed and replaced with 70 µl of test solution. The membranes were then placed on top of the cells and allowed to incubate at 37 °C in a humidified CO2 incubator for 30 min. The membranes were then carefully removed from the cells and allowed to dry completely and fixed with powdered paraformaldehyde at 80 °C for 1 h. Fixed membranes were rinsed in phosphate-buffered saline (PBS; 1 mM KH2PO4, 10 mM Na2HPO4, 137 mM NaCl, 2.7 mM KCl) containing 1% Triton X-100 (PBS-T) to remove excess paraformaldehyde and blocked with PBS-T containing 3% fetal bovine serum for 30 min at room temperature. The membranes were incubated with anti-substance P antibody (Santa Cruz Biotechnologies) at 1:200 dilution in PBS-T with 1% fetal bovine serum overnight in 37 °C incubator. The next day the membranes were developed with a peroxidase/diaminobenzidine reaction using the ABC staining kit from Santa Cruz Biotechnology. Images were taken using a CCD camera and analyzed using Photoshop and National Institutes of Health image software. Data were plotted by assigning an upper and lower limit of gray values and plotting the percent of cells at a range within those limits. By plotting graphs as percent of cells in a dynamic range, multiple experimental runs (n = 4) were pooled.
Binding of Endogenous Ankyrin B to 795814 Channel PeptidesAffinity columns were prepared by incubating 100 µg of N-terminally biotinylated, synthetic 795814 or scrambled peptides with streptavidin-Sepharose beads as per the manufacturer's instructions (Pierce). 2 mg of DRG lysate was loaded onto the biotinylated peptide-avidin column and incubated for 4 h at 4°C. Elution was performed as per the manufacturer's instructions (Pierce). Eluates were mixed with Laemmli sample buffer and resolved by 7.5% SDS-polyacrylamide gel electrophoresis. Immunodetection of ankyrin B was carried out using anti-ankyrin B antibody (1:1000, BD Transduction Laboratories).
| RESULTS |
|---|
|
|
|---|
-conotoxin GVIA to visualize the channels in the surface of live DRG neurons. We found a punctate distribution of channels in the top plane of the membrane which was rapidly (within 2 s) reduced by the application of baclofen, a GABAB receptor agonist (100 µM) and a well established modulator of these channels (Fig. 1a). The decrease in fluorescence was transient as channel puncta reappeared at the cell surface with some delay (within several minutes) under the continued presence of the transmitter (Fig. 1, a and b). The flow of saline had no effect on channel distribution (Fig. 1a). Experiments in which x-y optical slices were taken before and during agonist application showed a loss of florescence signal in the top surface that was accompanied by an increase in fluorescence in the middle optical slice (Fig. 1c). When the neurons are in saline, most of the fluorescence signal is in the top surface or membrane-associated (Fig. 1d). Upon exposure to the agonist, most of the fluorescence is found in the middle optical slices (Fig. 1d). In experiments in which the transmitter was applied for a 20-s interval followed by a washout with saline, the fluorescence signal reappeared to the cell surface within 10 s (see Fig. 5d, control).
Preincubation of DRG neurons with unlabeled toxin prevents the binding of rhodamine-conjugated
-conotoxin GVIA, demonstrating that the probe binds selectively (Supplemental Fig. 1a). Because
-conotoxin GVIA blocks the channel pores, these results suggest that the trafficking of calcium channels does not require calcium influx through the Cav2.2 channel.
|
The reduction in surface label was associated with an increase in cytoplasmic label, as shown by imaging of optical slices from top to bottom at 240-nm intervals from fixed DRG neurons (Fig. 2). Calcium channels were detected using an anti-pan
1 antibody that recognizes 13821400 of the rat
1 subunit from skeletal muscle, a region conserved across all the
1 subunits of high voltage-activated calcium channels. Because DRG neurons express only Cav2.2 calcium channels (13), this antibody can be used, and it has the advantage of not binding the SNARE binding region. Optical slices from saline-treated neurons show that the channel is associated with the top slices; in the middle slices the fluorescence signal forms a ring around the periphery of the cell, suggesting that association with the membrane (Fig. 2). Upon exposure to agonist, the fluorescence signal becomes more intense in the middle slices, and the channels appear not to be membrane-associated (Fig. 2, a and b). Preincubation of the antibody with a peptide containing the epitope sequence blocks the signal (Supplemental Fig. 1b), demonstrating specificity. Together these results suggest that activation of G protein-coupled receptors induces movement of calcium channels from the plasma membrane to the cytoplasm.
|
The punctate distribution of fluorescence in the cytosol suggests that Cav2.2 channels are likely to be sequestered into vesicles. To test this idea we determined whether Cav2.2 channels co-distributed with the vesicle-associated proteins Rab5 (an early endosome marker) and clathrin (clathrin-coated vesicle marker). Under saline or control conditions, a low level of co-localization was observed between the calcium channels and either Rab5 or clathrin heavy chain (Fig. 3a). After a 20-s exposure to baclofen, however, there is an increase in the degree of co-localization of the calcium channels with Rab5, from 0.05 ± 0.0085 in saline-treated neurons to 0.80 ± 0.07 in baclofen-treated cells (Fig. 3, a and b). Similar results were observed for clathrin heavy chain. These results suggest that upon application of agonist, Cav2.2 channels are removed from the plasma membrane and sequestered into clathrin-coated vesicles.
Gi/o Mediates Removal of Cav2.2 ChannelsTransmitter-induced inhibition of voltage-dependent calcium channels is mediated through the activation of pertussis toxin-sensitive, heterotrimeric Gi/o proteins (16). To determine whether activation of Gi/o is required for agonist-induced removal of calcium channels from the membrane, DRG neurons were pretreated with 100 ng/ml pertussis toxin for 16 h before exposure to transmitter or saline. Pertussis toxin treatment blocked transmitter-induced removal of Cav2.2 channels (Fig. 4, a and b).
GABA activates separate signaling pathways to inhibit Cav2.2 channels in chick DRG neurons; one that is voltage-independent and involves tyrosine kinase (17) and a second one that mediates voltage-dependent inhibition by direct binding to the channel (2, 3). To test whether G
subunits mediate the trafficking of calcium channels, we used a cell-permeant peptide containing the G
binding region of the
-adrenergic receptor kinase. The N terminus of the peptide contains a biotin group and an Antennapedia penetratin (AP) domain that allows the peptide to permeate the membrane. We have previously used this peptide to prevent G
-mediated inhibition of calcium current in chick DRG neurons (10). Cells were pretreated in medium containing 1 µg/ml peptide for 1 h before the experiment. Control experiments were performed in which the biotinylated peptides were detected with fluorophore-conjugated streptavidin to determine whether the peptide was present in the cell cytoplasm (Supplemental Fig. 2A). Pretreatment with the peptide failed to alter calcium channel trafficking induced by the GABAB receptor agonist baclofen (Fig. 5, a and b), suggesting that G protein 
subunits are not mediating this process.
|
Pretreatment of neurons with sodium orthovanadate to block tyrosine phosphatases potentiated the internalization of calcium channels induced by baclofen, suggesting that tyrosine phosphorylation plays a role in baclofen-induced channel trafficking. In the presence of orthovanadate the magnitude of the response was larger, as measured by the loss of fluorescence from the top surface (Fig. 5d). In addition, recovery after agonist washout was slower compared with control cells. We have previously reported similar effects of orthovanadate on baclofen-mediated inhibition of calcium current (17).
We had previously reported that injection of active Src kinase mimicked GABAB receptor voltage-independent inhibition, whereas injection of antibodies raised against Src kinase blocked this inhibitory component (25). Active Src kinase induced calcium channel internalization in the absence of receptor activation (Fig. 5e), further suggesting that tyrosine kinase activation is required for internalization. To test the role of Src kinase on channel internalization, we injected antibodies raised against members of the non-receptor tyrosine kinase family. Injection of antibodies selective for p60Src prevented baclofen-induced channel internalization (Fig. 5f). Antibodies raised against PY2 or Yes were without effect.
These results together with the lack of effect of the cell-permeant peptide containing the G
binding region of the
-adrenergic receptor kinase, the requirement of p60Src kinase for internalization, and the results of the electrophysiological recordings (Supplemental Fig. 1d) suggest that the transmitter-mediated trafficking of calcium channels plays a role in the voltage-independent component of calcium current inhibition.
Disruption of L1-CAM-Ankyrin B Interaction Induces Removal of Cav2.2 Channels from the Plasma MembraneThe fluorescent puncta are likely to represent clusters of many calcium channels. Such clusters might require the interaction of the channels with cytoskeletal components. The receptor-induced removal of calcium channels from the membrane raises the possibility that activation of heterotrimeric G proteins causes disruption of cytoskeletal elements that might anchor the channels in the membrane. Although the mechanisms of synaptic targeting of calcium channels have been widely studied (18), the molecular mechanisms involved in the retention of Cav2.2 channels at the plasma membrane are largely unknown. The best-characterized example of selective retention of a voltage-dependent ion channel is that of the anchoring of Nav channels through indirect interactions with L1 family member neurofascin in neurons (19). Based on what is known about the retention and membrane organization of Nav channels, we tested whether L1-CAM-ankyrin interaction plays a role in the retention of calcium channels in the membrane. We employed a cell-permeant peptide that disrupts L1-CAM-ankyrin B interaction (AP-YF peptide, Ref. 20). This peptide has two domains; they are an Antennapedia penetratin domain that allows the peptide to permeate the membrane and the 12-amino acid ankyrin interaction domain of L1-CAM with the terminal tyrosine residue replaced with a phenylalanine (21). Pretreatment of DRG neurons with AP-YF peptide (1.4 µg/ml, 30 min) induces removal of Cav2.2 channels in a manner similar to that mediated by G proteins (Fig. 6, a and b). The peptide produces a change in the subcellular distribution of calcium channels from the membrane to the cytosol similar to that induced by baclofen (Fig. 6b). Under these experimental conditions calcium channels are found in the cytoplasm of the neurons in the absence of receptor activation. A scrambled peptide (Scr) in which the L1-CAM domain sequence is reversed had no effect (Fig. 6a).
Under saline conditions there is a significant degree of co-localization between the calcium channels and ankyrin B and L1-CAM (Fig. 6c). After treatment with neurotransmitter, Cav2.2 channels move to the cytoplasm, whereas L1-CAM and ankyrin are not endocytosed with the channels (Fig. 6c) and stay at the plasma membrane. These results suggest that L1-CAM-ankyrin interaction function to retain Cav2.2 channels at the plasma membrane.
Consequences of Disruption of L1-CAM-Ankyrin Interaction on Calcium Channel ActivityWe tested the effect of disrupting L1-CAM-ankyrin B-containing complexes on whole-cell calcium currents in embryonic chick DRG neurons. Because these neurons only express Cav2.2 channels, the voltage-dependent calcium current measured under our experimental conditions are carried through these channels. AP-YF or Scr peptide was introduced into the cytoplasmic environment by passive diffusion through the recording pipette, and calcium current was measured as a function of time. AP-YF peptide (1.4 ng/ml) inhibited calcium current by 83 ± 17% after 2 min of recording (Fig. 7, a and b), whereas the scrambled peptide had no significant effect.
Inhibition of calcium influx by AP-YF peptide should result in alterations of calcium-dependent processes such as exocytosis. To examine this question directly, we measured secretion of substance P from chick DRG neurons using single-cell blot secretion assays (12). After the method developed by Neher and Huang (12), the density of the chemiluminescence signal for substance P was measured for individual DRG neurons. The frequency of cells showing a given value or density was plotted for different experimental conditions. High K+-induced depolarization causes secretion of substance P from DRG neurons, whereas cells in low K+ secrete low levels of substance P (Fig. 7c). Preincubation of neurons with AP-YF peptide blocks high K+-induced secretion, decreasing secretion to levels observed in low K+ (Fig. 7c). Baclofen has an additional effect on AP-YF peptide-induced inhibition of secretion, with 75% of DRG neurons secreting low levels of substance P. The scrambled peptide did not affect secretion significantly. These results demonstrate that under experimental conditions in which we have observed removal of calcium channels, AP-YF peptide causes a robust inhibition of high K+-induced secretion of substance P. The results from the secretion assays show that the disruption of the L1-ankyrin B interaction results in a decrease in the K+-induced secretion to the levels observed under non-depolarizing conditions. This is consistent with a loss of calcium channels in the plasma membrane; even if the neurons are depolarized, calcium influx is reduced.
Activation of G Protein-coupled Receptors Disrupts the Interaction of Calcium Channels with the L1-CAM-Ankyrin ComplexBecause AP-YF peptide mimics G protein-mediated removal of calcium channels from the membrane, we tested whether calcium channels directly associate with L1-CAM and ankyrin B and if so, whether activation of G protein-coupled receptors alters the association. L1-CAM and ankyrin B co-precipitate with Cav2.2 channel protein from chick DRG neurons treated with saline; when we probed for L1-CAM the main bands were observed in the 200220-kDa region, in agreement to published reports. When membranes were probed for ankyrin B, bands were observed at around 220 and 150 kDa, in agreement with the predicted size for ankyrin B. Pretreatment with AP-YF but not Scr abolished the interaction (Fig. 8, a and b). Activation of GABAB receptors (Fig. 8, panels a and b; Supplemental Fig. 2) reduced the amount of L1-CAM and ankyrin B that co-precipitated with the calcium channel. These results suggest that activation of G protein-coupled receptors results in disruption of a complex containing L1-CAM, ankyrin B, and Cav2.2. Furthermore, interaction with L1-CAM seems to be necessary for ankyrin B binding to the calcium channel.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The activation of G protein-coupled receptors destabilizes the channels from the plasma membrane and might disrupt interactions that mediate the retention of Cav channel in the membrane. Voltage-dependent sodium channels have been shown to interact with the L1-family member neurofascin and ankyrin G at the axon initial segment and nodes of Ranvier (26). However, this interaction is stable in nature and has not been demonstrated to be altered by receptor activation. Our data suggest that L1-CAM-ankyrin B interaction is required for retention of the calcium channel at the plasma membrane as well but that this interaction is dynamic and regulated (Fig. 9c). The basis for the dynamic nature of the L1-CAM-ankyrin B-calcium channel interaction seems to reside on the modulation of calcium channels by G protein-coupled receptors. The disruption of L1-CAM-ankyrin B interaction by the AP-YF peptide mimics the effects of activation of G protein-coupled receptors. One potential mechanism by which G protein-coupled receptors could disrupt this interaction is by phosphorylation of one of the components of the complex. Previous data from our laboratory have shown that, upon activation of GABAB receptor, the
1 subunit of the channel becomes tyrosine-phosphorylated; one of the phosphorylation sites is residue Tyr-804, which is contained within the 795814 channel region required for ankyrin B binding (27). The phosphorylation of this residue abrogates ankyrin binding, providing a potential mechanism for G protein-mediated disruption of the L1-CAM-ankyrin B-channel complex (Fig. 9c). It is not known whether activation of G protein-coupled receptors can result in the phosphorylation of other components of the complex such as ankyrin B or L1-CAM. L1-CAM is known to be a substrate for both serine-threonine (28) and tyrosine kinases (29). Phosphorylation of L1 family members at the highly conserved FIGQY sequence disrupts their binding to ankyrin (21). We also cannot exclude the involvement of other molecules that could bridge the interaction between L1-CAM-ankyrin B with the calcium channel.
|
1 subunit of Cav2.1 calcium channels. In the absence of this region Cav2.1 calcium channels were inserted in the membrane of the somata (22). The results presented here suggest that interaction of L1-CAM-ankyrin B with the SNARE binding or synprint region of the Cav2.2 channel is needed for retention of these channels in the plasma membrane. Disruption of L1-CAM-ankyrin B interaction abolishes association of ankyrin with the calcium channel. One potential interpretation of this observation is that the interaction with L1-CAM stabilizes or facilitates the interaction of ankyrin B with the calcium channel. Most of the information on the subcellular distribution of voltage-dependent calcium channels comes from developmental studies on the formation of the presynaptic active zones. These studies have shown that voltage-dependent calcium channels are localized to the Bassoon-containing active zone precursor vesicles (30). Our results suggest that transmitters can induce trafficking of calcium channels. This transmitter-induced trafficking is a different process from the compensatory endocytosis described in presynaptic terminals. The G protein-coupled receptors used in our studies inhibit calcium channels and exocytosis, whereas compensatory endocytosis takes place after opposite events, calcium influx and exocytosis, to retrieve the contents of the synaptic vesicles (31). Furthermore, we have observed internalization of syntaxin, whereas this is not the case in compensatory endocytosis (32).
Lateral diffusion in the plane of the membrane has been suggested to play a role in the regulation of receptor function at the cell surface of the postsynaptic density (33). For instance, activity-dependent lateral diffusion of AMPA receptors has been postulated to regulate receptor activity in the postsynaptic density (34). The experiments presented here do not exclude the possibility that movement of calcium channels in the plasma membrane might be sufficient to interfere with calcium channel activity prior to endocytosis.
Removal of calcium channels from the plasma membrane induced by AP-YF results not only in a decrease in calcium current but in the inhibition of calcium-dependent processes such as secretion of substance P. We cannot discard the possibility that L1-CAM-ankyrin interaction could play a role in anchoring elements of the exocytic machinery. However, because the loss of secretion closely parallels the loss of Cav2.2 channels at the cell surface and its associated calcium current, the loss of secretion resulting from the inhibition of calcium influx is the simplest interpretation of this result.
Because calcium channels play a pivotal role in synaptic transmission, a change in the number of channels available in the plasma membrane could have important physiological consequences. Although these changes in the number of functional calcium channels will have consequences in short-term modulation of presynaptic activity, future studies will focus on the long-term physiological consequences of this reorganization. The mechanism described in this paper could be physiologically relevant to CNS neurons such as the synaptic depression induced by the dendritic release of GABA from bitufted neurons, which activate presynaptic GABAB receptors in pyramidal neurons (35).
Numerous studies have shown activity-dependent reorganization of the postsynaptic density. In the presynaptic active zone, accurate calcium signaling requires the proper spatiotemporal organization of voltage-gated calcium channels and signaling molecules. We cannot preclude the possibility that other components of the active zone are sequestered along with the calcium channels, raising the possibility that this is part of a more extensive remodeling of the active zone. Our results demonstrate the dynamic nature of the organization of the active zone and its regulation by the activation of G protein-coupled receptors, a process that has important implications for the modulation of synaptic function.
| FOOTNOTES |
|---|
The on-line version of this article (available at http://www.jbc.org) contains Supplemental Figs. 1 and 2. ![]()
1 These authors contributed equally to the paper. ![]()
2 To whom correspondence should be addressed: Mount Sinai School of Medicine, Dept. of Pharmacology and Biological Chemistry, One Gustave L. Levy Place, Box 1603, New York, NY 10029. Tel.: 212-241-5569; Fax: 212-996-7214; E-mail: maria.diverse{at}mssm.edu.
3 The abbreviations used are: DRG, dorsal root ganglion; GABA,
-aminobutyric acid; PIPES, 1,4-piperazinediethanesulfonic acid; PBS, phosphate-buffered saline; AP, Antennapedia penetratin; SNARE, soluble N-ethylmaleimide factor attachment protein receptor, H, heavy chain; L, light chain. ![]()
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|